However, NOS3 expression in STAD patients did not show difference in early and advanced tumor stage (early stage: mean of NOS3 expression = 9.888 ± 0.9934; advanced stage: mean = 9.872 ± 1.025, p = 0.6653) (Supplementary Figure 3). Here, NOS3 is linked to gastric adenocarcinoma.